首页> 外国专利> FGFR FGFR INHIBITOR FOR USE IN THE TREATMENT OF HYPOPHOSPHATEMIC DISORDERS

FGFR FGFR INHIBITOR FOR USE IN THE TREATMENT OF HYPOPHOSPHATEMIC DISORDERS

机译:FGFR FGFR抑制剂用于治疗低血钾症

摘要

The invention generally adopts X-related hypophosphoric rickets (XLH),Hypophosphatemic rickets (ADHR) on the upper chromosome,ArhR,Tumor induced osteomalacia,Hypophosphate blood after kidney transplantation.Epidermic treason syndrome.To treat osteogenesis or McQueen Albright syndrome,3 - (2, 6-di, 6, dichloro-3, 5, 5, dimethoxy-benzene) - 1. {6 - [4 - (4-ethyl-piperazine-1-one) - benzopyrene (benzyl urea or the salt or solvent cargo permitted by its restriction,Or 3 - (2,6-dichloro-3,5-dimethyl-benzene) - 1. {6 - [4 - (4-ethyl-piperazine-1-one) - benzopyrene (benzopyrene) - pharmaceutical composition containing a salt or solvent for its restriction.
机译:本发明一般采用X相关性低磷病(XLH),上染色体低磷病(ADHR),ArhR,肿瘤引起的骨软化症,肾移植后低磷血性。病叛逆综合征,用于治疗成骨或McQueen Albright综合征,3-( 2,6-二,6,6,三氯3,5,5,二甲氧基-苯)-1. {6- [4--(4-乙基-哌嗪-1-酮)-苯并re(苄基脲或盐或溶剂受其限制允许的货物,或3-(2,6-二氯-3,5-二甲基苯)-1. {6-[4-(4-乙基-哌嗪-1-酮)-苯并re(苯并py)-含有盐或溶剂对其限制的药物组合物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号